1.
Dattola A, Sasso FP, Marotta G, Rizzuto G, Bernardini N, Persechino S, et al. Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region. Dermatol Pract Concept [Internet]. 2026 Jan. 30 [cited 2026 Jun. 1];16(1):7116. Available from: https://dpcj.org/index.php/dpc/article/view/7116